Experts from Isomorphic Labs discuss their AI-driven 'drug design engine,' which uses models like AlphaFold to accelerate drug discovery. They aim to replace slow, physical lab work with rapid 'in silico' virtual testing to create novel treatments for diseases like cancer.

An unnamed speaker, presumably from Isomorphic Labs, discusses the company's mission to solve all diseases using a general AI platform. He outlines their progress, current preclinical stage, and focus on oncology and immunology.

Demis Hassabis of Google DeepMind discusses the need for a tiered approach to AI regulation, distinguishing between powerful frontier models and smaller open-source ones. He emphasizes AI's potential for productivity gains and scientific breakthroughs, while viewing AGI as still being years away.